论文部分内容阅读
目的分析腹腔镜手术治疗卵巢良性上皮性肿瘤的临床疗效及安全性。方法选取2011年1月至2013年1月间收治的卵巢良性上皮性肿瘤患者100例。按照随机数表法分为对照组和观察组,每组50例。对照组患者采取开腹手术治疗,观察组患者采取腹腔镜手术治疗,观察并比较两组患者术后的疗效。结果观察组患者手术时间、术中出血量、肛门排气时间、下床活动时间、住院时间分别为(50.3±10.3)h、(40.8±12.3)ml、(13.3±4.7)h、(4.8±1.7)d、(3.8±1.2)d,均明显低于对照组,差异有统计学意义(P<0.05)。观察组患者术后1个月、6个月、1年的FACT-G评分分别为(67.6±8.4)分、(83.7±10.2)分和(89.7±10.4)分,均明显高于对照组,差异有统计学意义(P<0.05)。观察组术后有2例(4.0%)患者使用镇痛药,术后并发症发生率及术后1年肿瘤复发率分别为8.0%和0,均明显低于对照组,差异有统计学意义(P<0.05)。结论腹腔镜手术对卵巢良性上皮性肿瘤患者的治疗效果优于开腹手术,是一种安全、有效的治疗方法,值得在临床上广泛推广。
Objective To analyze the clinical efficacy and safety of laparoscopic surgery for benign epithelial ovarian tumors. Methods 100 patients with benign ovarian epithelial tumors who were admitted between January 2011 and January 2013 were enrolled. According to the method of random number table divided into control group and observation group, 50 cases in each group. The patients in the control group were treated by laparotomy. The patients in the observation group were treated with laparoscopic surgery. The postoperative efficacy of the two groups was observed and compared. Results The operation time, intraoperative blood loss, anal exhaust time, ambulation time and hospital stay in the observation group were (50.3 ± 10.3) h, (40.8 ± 12.3) ml, (13.3 ± 4.7) h and 1.7) d and (3.8 ± 1.2) days, all of which were significantly lower than those of the control group (P <0.05). The FACT-G scores of one month, six months and one year after operation in the observation group were (67.6 ± 8.4), (83.7 ± 10.2) and (89.7 ± 10.4) points respectively, which were significantly higher than those in the control group The difference was statistically significant (P <0.05). Two patients (4.0%) in the observation group were given analgesics. The incidence of postoperative complications and tumor recurrence rate at 1 year after surgery were 8.0% and 0, respectively, which were significantly lower than those in the control group (P <0.05). Conclusions Laparoscopic surgery is superior to laparotomy in the treatment of patients with benign epithelial ovarian tumors. It is a safe and effective treatment and is worth popularizing in clinic.